Navigation

Search This Site

Office of the Vice President for Research

Opportunities Related to COVID-19

Resources for Researchers Related to COVID-19

 

Funding Opportunities Related to COVID-19

The following table lists funding opportunities relating to the COVID-19 virus. We will continue to update this list as new opportunities become available. If you would like to add opportunities to this list please feel free to contact Dean Evasius.

Sponsor

Program Name and Link

First Due Date(s)

Notes

ADA American Diabetes Association COVID-19 and Diabetes Research Award 5/22/2020 The American Diabetes Association (ADA) is requesting applications for research focused on the impact of diabetes on COVID-19 and the impact of COVID-19 on diabetes and its complications. The expedited application deadline will be 5pm ET on May 22, 2020 for July 1, 2020 funding.
AHA AHA Rapid Response Grant COVID-19 and Its Cardiovascular Impact 4/6/2020 Grant amounts will be up to $100,000. AHA anticipates funding at least 10 awards.
Amazon AWS Diagnostic Development Initiative (DDI) 6/30/2020 Provides support for innovation in rapid and accurate patient testing for 2019 novel coronavirus (COVID-19), and other diagnostic solutions to mitigate future outbreaks.
AHRQ Notice of Intent: New Funding Opportunity Announcement to Support Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19   AHRQ is working to publish the FOA in early May 2020 with submissions due in June 2020.The health systems research community should prepare to submit applications to AHRQ to fund critical research focused on evaluating topics such as innovations and challenges encountered in the rapid expansion of telemedicine in response to COVID-19, effects on quality,
American Lung Association COVID-19 Action Initiative   The American Lung Association is launching a $25M initiative to end COVID-19 and defend against future respiratory virus pandemics.
BARDA Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) 4/30/2020  
Campus Consortium C19 Artificial Intelligence for Rapid Response Grant 4/3/2020 Designed to help schools address the high call and query volume they are receiving by providing Unifyed’s Yoda Rapid Response, an AI-enabled chat service that can help answer FAQ and provide self-help assistance to students, faculty and staff. The Artificial Intelligence for Rapid Response Grant will provide awarded institutions with the requisite licenses and services to a comprehensive Artificial Intelligence solution.
CDC Strengthening Global Field Epidemiology Training Program (FETP) Network 4/27/2020
Development of a well-trained epidemiologic public health workforce in surveillance, outbreak detection and response is essential in meeting Global Health Security objectives.
CDC Enhancing Global Health Security: Expanding Efforts and Strategies to Protect and Improve Public Health Globally 4/27/2020 The CDC seeks to accelerate progress toward a world safe and secure from infectious disease threats and to promote global health security as an international security priority.
CDC Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nations Health 4/2/2020 This is a forecast for an emergency supplemental funding opportunity announcement in response to the current outbreak of Coronavirus disease 2019 (COVID-19).
CDC CDC Coronavirus Response Fellowship 5/1/2020  The qualified candidate should be pursuing or have completed a degree in one of the relevant fields.
CDC Centers for Disease Control COVID-19 Broad Agency Announcement 3/25/2020  
CISCO

Pandemic/COVID19 Science, Technology and Social Impact

Continuous Pandemics have far reaching consequences that range from deaths to shutting down the economy as we have witnessed during the recent COVID19 crisis. Hence there is a need to be better prepared for such pandemics. We need to solve problems ranging from predictive analytics innovative devices for saving lives to technology for devising voting machines. The social and economic impact for the above areas is huge and some of the work can be transformative and save lives.
DTRA Strategic Trends Division Broad Agency Announcement (BAA) 3/4/2020 Posted March 4, 2020
DOD Newton Award for Transformative Ideas during the COVID-19 Pandemic 5/15/2020 This award will be presented to a single investigator or team of up to two investigators that develops a “transformative idea” to resolve challenges, advance frontiers, and set new paradigms in areas of immense potential benefit to DoD and the nation at large. Proposals should aim to produce novel conceptual frameworks or theory-based approaches that present disruptive ways of thinking about fundamental scientific problems that have evaded resolution, propose new, paradigm-shifting scientific directions, and/or address fundamental and important questions that are argued to be undervalued by the scientific community
DOD Prototype Development to Combat Novel Coronavirus Disease COVID-19 4/15/2020 The Medical Technology Enterprise Consortium (MTEC) is excited to post this pre-announcement for a potential Request for Project Proposals (RPP) focused on the development of prototypes aimed to combat the coronavirus (COVID-19).
DOD-Army xTech COVID-19 Ventilator Challenge   The ventilator challenge is open to all US-based entities and is currently accepting applications. Submissions that are approved by the judging panel will receive an invitation to conduct a virtual pitch to a panel beginning on April 13, 2020.
DOD-Army CDMRP PRMRP Technology/Therapeutic Development Award for Emerging Viral Diseases and Respiratory Health 6/8/2020 This award supports the “rapid implementation” of clinical trials for Emerging Viral Diseases and/or Respiratory Health. Clinical trials may be designed to evaluate “new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies.” Projects may range from small proof-of-concept trials to large-scale trials. CDMRP anticipates a total of $30 million available in funding for five awards. Pre-applications are due by June 8, 2020 at 5:00pm ET and applications are due by June 22, 2020 by 11:59pm ET.
DOD-Army CDMRP PRMRP Investigator-Initiated Research Award for Emerging Viral Diseases and Respiratory Health 5/28/2020

The PRMRP Investigator-Initiated Research Award is intended to support studies that will make an important contribution toward research and/or patient care in one or more Focus Areas published in this Funding Opportunity for the FY20 PRMRP Topic Areas of Emerging Viral Diseases and/or Respiratory Health.Research projects should focus on basic laboratory research through translational research. CDMRP anticipates a total of $12 million available in funding for four awards. Pre-applications are due by May 28, 2020 at 5:00pm ET and applications are due by June 12, 2020 at 11:59pm ET.

DOE Dear Colleague Letter on DOE Resources for COVID-19 Research   Please send research questions that the scientific community may address with DOE resources by email to SC.DCL@science.doe.gov. Responses will be reviewed beginning March 18, 2020
Dept. of State Pandemic Propaganda and Disinformation in Africa.   7/22/2020 The Department of State Global Engagement Center (GEC) released a Notice of Funding Opportunity (NOFO), with funding appropriated in the CARES Act, to address Pandemic Propaganda and Disinformation in Africa.  GEC is specifically seeking proposals for activities that address the following in Kenya, Nigeria, and certain countries in the Sahel region: o “Proactively Address Harmful COVID-19-Related Propaganda and Disinformation from Malign State and Non-State Actors Targeting the United States and its Partners o Strengthen Influencers’ Capacity to Recognize and Counter COVID-19-Related Propaganda and Disinformation” Proposals are due no later than Wednesday, July 22, 2020 at 11:30 PM EDT.  Up to $2.5 million will be available 2-4 awards that will range from $625,000 to $1.25 million.  This solicitation is open to U.S. and foreign non-profit organizations, institutions of higher education, and commercial entities.  Interested applicants must create an account in the State Department’s official application portal https://mygrants.servicenowservices.com/ilms/portal_login.do to see the full solicitation.  
ERI ERI Rapid Response Grant Opportunity 5/22/2020 Rapid Response grants will be funded up to $15,000.  ERI will provide funds for specific and time-sensitive opportunities to help faculty, postdoctoral fellow, and students conduct studies that do not require being in the laboratory or travel.
FastGrants Fast Funding for COVID-19 Science   If you are a scientist at an academic institution currently working on a COVID-19 related project and in need of funding, we invite you to apply for a Fast Grant. Fast Grants are $10k to $500k and decisions are made in under 48 hours. If we approve the grant, you'll receive payment as quickly as your university can receive it.Fast Grants open at 12:00 Pacific Time on Tuesday, April 7, 2020. We will wait until Sunday, April 12 before we award our first grants in order to give our reviewers time to calibrate. Subsequent decisions will be made within 48 hours.
Foundation for Opioid Response Efforts

Strengthening Access to Care for Opioid Use Disorder Patients During the COVID-19 National Public Health Emergency: Recovery Support Services

7/31/2020 FORE will initiate rapid response grant support for specific projects that aim to strengthen access to evidence-based OUD recovery services for vulnerable and high-risk populations during the COVID-19 national emergency. This RFP targets projects which can provide recovery support services in the context of social distancing and infection control, including promotion of remote, digital, and virtual forms of recovery support to reach vulnerable and broader populations.
Gateway for Cancer Research GATEWAY GRANT APPLICATION REQUEST 6/22/2020 The oncology community must continue to urgently respond to the significant disruption of clinical trials caused by the COVID-19 pandemic. To that end, Gateway for Cancer Research is committing funding resources to advance solutions that better ensure continuity of patient access to investigational studies during this public health crisis or any future exogenous events that threaten the execution of clinical trials. Gateway will provide grants in the range of $400,000 to $600,000 in funding for direct costs of the research. The grant application may be submitted at any time, please contact Research@GatewayCR.org to receive instructions on how to access our grant management system
GIDI GIDI 2020-2021 Inequity in Infectious Disease Grant 8/1/2020 The Global Infectious Disease Institute is announcing a call for Inequity in Infectious Disease Grants. Structural racism impacts global health in myriad ways: it influences vulnerability to infectious disease, the availability of treatment, and the variability of outcomes, with the current COVID-19 pandemic being just the most recent example.  GIDI is opening a call for proposals focusing on sources and solutions for inequities in global infectious disease. Evidence based research is critical in the fight against systemic racism. 
GIDI COVID-19 Rapid Response Grants 3/27/2020 Rapid Response Grants from the UVA Global Infectious Diseases Institute (GIDI)
Harrington Discovery Institute Transatlantic Call for Proposals to Treat Coronavirus and its Clinical Impact 4/30/2020 HDI will select up to ten projects through the call for proposals and its current portfolio of drugs in development. Awarded projects will run for 12 months, with the possibility of extending the engagement.
HHS-HSRA Rural Tribal COVID-19 Response Program Department of Health and Human Services
Health Resources and Services Administration
5/6/2020 HRSA-20-135 
HHS-SAMHSA

COVID-19 Emergency Response for Suicide Prevention Grants

5/22/2020
FOA Number FG-20-007 SAMHSA has shortened the application timeline due to the acute need in many areas for immediate funding. If SAMHSA does not receive applications for the full funding amount available within this timeframe, the application period will be extended. Each entity will only receive one award from this announcement. Funds will be distributed on a rolling basis.
HUD

Fair Housing Initiatives Program - Education and Outreach Initiative (COVID-19)

7/8/2020 The purpose of this Notice is to seek applications from eligible entities that will create and disseminate fair housing education and outreach materials in COVID-19 affected areas.
IARPA IARPA Releases BAA Focused on COVID-19 Seedling Projects 7/7/2020 IARPA has issued a broad agency announcement (BAA) soliciting proposals for unclassified seedling projects across a range of topics that are relevant to COVID-19. The BAA explicitly calls for proposals that envision revolutionary, not evolutionary, capabilities, and that focus on research questions not currently being addressed by existing IARPA programs.   The full RFI can be found at https://beta.sam.gov under solicitation number “IARPA-BAA-20-01.” 
IMLS Federal Government Invests $50M in Museums, Libraries to Address Digital Divide During COVID-19   The Institute of Museum and Library Services today announced that the President has signed the CARES Act, which designates $50 million in coronavirus response funding for IMLS. Following passage in the House of Representatives earlier today, both chambers of Congress approved of the Coronavirus Aid, Relief, and Economic Security (CARES) Act, a $2 trillion response to the growing pandemic.
Internet Society Foundation Emergency Response Grant Programme: COVID-19 5/17/2020 This program will provide funding to organizations working on projects that utilize the Internet to improve lives during or in response to an emergency situation. In 2020, the Foundation’s focus will be on projects that respond to the COVID-19 pandemic, both during the immediate period of the crisis but also looking ahead at responses to the inevitable “second wave” later this year/into 2021.  
Ivy Foundation The Ivy Foundation COVID-19 Translational Research Fund 6/22/2020 The Charlottesville-based Ivy Foundation has committed $2 million to accelerate biomedical research focused on COVID-19 at the University of Virginia. The Ivy Foundation COVID-19 Translational Research Fund will support critical research that addresses COVID-19 diagnosis, treatment options, vaccine development and healthcare worker protection needs.
Mellon Foundation Coalition of Arts Funders Launches Emergency Artist Relief Fund   Artist Relief will distribute $5,000 grants to artists facing dire financial emergencies due to COVID-19.
Mozilla The Mozilla Open Source Support (MOSS) awards program   Tracks I and II and this new COVID-19 Solutions Fund accept applications on a rolling basis.
MTEC Wearable Diagnostic for Detection of COVID-19 Infection 5/13/2020 Enhanced White Paper Due Date: May 13 2020. The pandemic COVID-19, a disease caused by a novel coronavirus, continues to spread worldwide. There is a dire and urgent need for development of rapid, accurate wearable diagnostics to identify and isolate pre-symptomatic COVID-19 cases and track/prevent the spread of the virus.
 
MTEC Pre-Announcement for MTEC-20-10-COVID19-NETCCN - "National Emergency Telecritical Care Network (NETCCN) Project"    This upcoming RPP will focus on enhanced development of integrated technologies and clinical workflows to establish and rapidly scale virtual wards.
MTEC Development of Treatments for COVID-19 4/8/2020

FOCUS AREA: Therapeutic(s) that can treat COVID-19.  Treatments with potential application to the prevention of COVID-19 infection are desired.  Therapeutics that can be administered in a non-hospital environment are desired. Potential applicants should work with their school’s respective grants offices to submit the white paper.

MTEC Solicitation Number: MTEC-20-10-COVID-19_NETCCN_TATRC “National Emergency Telecritical Care Network (NETCCN)” 4/27/2020 Enhanced White Paper Due Date: April 27, 2020 (MTEC) is excited to post this announcement for a Request for Project Proposals (RPP) to rapidly develop and deploy the National Emergency Telecritical Care Network (NETCCN) - a cloud-based, low-resource, stand-alone health information management system for the creation and coordination of flexible and extendable “virtual critical care wards.” These high acuity, virtual wards would bring high-quality critical care capability to nearly every bedside, be it healthcare facility, field hospital, or gymnasium.  
MTEC Prototype Development to Combat Novel Coronavirus Disease COVID-19 4/15/2020 This pre-announcement has been developed by MTEC to provide notice for the possibility of one or more upcoming RPPs focused on combating COVID-19.
NEA CARES Act Guidelines: Grant Program Description 4/22/2020 The National Endowment for the Arts will award funds to nonprofit arts organizations across the country to help these entities and their employees endure the economic hardships caused by the forced closure of their operations due to the spread of COVID-19.
NIH Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional) 8/20/2020 PAR-20-243. This Funding Opportunity Announcement (FOA) aims to support research to strengthen the healthcare response to Coronavirus Disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and future public health emergencies, including pandemics. While research related to the direct clinical effects of COVID-19 are supported by other funding opportunities, the purpose of this funding opportunity is to focus on the role and impact of digital health interventions [e.g., mobile health (mhealth), telemedicine and telehealth, health information technology (IT), and wearable devices] to address access, reach, delivery, effectiveness, scalability and sustainability of health assessments and interventions for secondary effects (e.g., behavioral health or self-management of chronic conditions) that are utilized during and following the pandemic, particularly in populations who experience health disparities and vulnerable populations.
NIH Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations 7/8/2020 NOT-OD-20-120 This Notice of Special Interest (NOSI) highlights the urgent need to understand and address COVID-19 morbidity and mortality disparities among underserved and vulnerable populations across the United States. These two-year community-engaged Testing Research Projects will examine SARS-CoV-2 infection patterns and efforts to increase access and effectiveness of diagnostic methods through the Rapid Acceleration of Diagnostics for Underserved Populations (RADx-UP) initiative. The overarching goal is to understand factors that have led to disproportionate burden of the pandemic on these underserved populations so that interventions can be implemented to decrease these disparities.
NIH Notice of Special Interest (NOSI): Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations 8/7/2020 NOT-OD-20-121 This Notice of Special Interest (NOSI) highlights the urgent need to understand and address COVID-19 morbidity and mortality disparities among underserved and vulnerable populations across the United States. These two-year community-engaged Testing Research Projects will examine SARS-CoV-2 infection patterns and efforts to increase access and effectiveness of diagnostic methods through the Rapid Acceleration of Diagnostics for Underserved Populations (RADx-UP) initiative. The overarching goal is to understand factors that have led to disproportionate burden of the pandemic on these underserved populations so that interventions can be implemented to decrease these disparities.
NIH Emergency Awards: RADx-UP Coordination and Data Collection Center (CDCC) (U24 Clinical Trial Optional) 7/8/2020 RFA-OD-20-013 NIH is issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS, for 2019 Novel Coronavirus (COVID-19). This emergency cooperative agreement funding opportunity announcement (FOA) from the National Institutes of Health (NIH) provides an expedited funding mechanism as part of the Rapid Acceleration of Diagnostics-Underserved Populations (RADx-UP) initiative, a consortium of community-engaged research projects to understand factors that have led to disproportionate burden of the pandemic on the underserved and/or vulnerable populations so that interventions can be implemented to decrease these disparities. T
NIH NIH mobilizes national innovation initiative for COVID-19 diagnostics 4/29/2020 The National Institutes of Health announced a new initiative aimed at speeding innovation, development and commercialization of COVID-19 testing technologies, a pivotal component needed to return to normal during this unprecedented global pandemic.
NIH Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences 4/13/2020 Notice Number: NOT-OD-20-097. This Notice of Special Interest (NOSI) highlights the urgent need for social, behavioral, economic, health communication, and epidemiologic research relevant to the 2019 Novel Coronavirus (SARS-CoV-2) and COVID-19.
NIH Notice of Common Fund’s Participation in PA-20-135 "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)"   Notice Number: NOT-RM-20-016. The purpose of this Notice to inform potential applicants that the Office of Strategic Coordination (Common Fund) will participate, effective immediately, in PA-20-135" Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)."
NIH Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)   continuous submission
NIH-AHRQ Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19 (R01) 6/15/2020 RFA-HS-20-003 This Funding Opportunity Announcement (FOA) invites R01 grant applications for funding to support novel, high-impact studies evaluating the responsiveness of healthcare delivery systems, healthcare professionals, and the overall U.S. healthcare system to the COVID-19 pandemic
NIH-AHRQ Competitive Revision Supplements to Existing AHRQ Patient Centered Outcomes Research (PCOR) Grants and Cooperative Agreements to Evaluate Health System and Healthcare Professional Responsiveness to COVID-19 (Supplement -  Clinical Trial Optional) 5/29/2020 PA-20-072. Applications are due by May 29, 2020 by 5:00 PM local time of applicant organization.   
NIH-AHRQ Notice of Intent: Revision Supplements to Existing AHRQ Grants and Cooperative Agreements to Address Health System Responsiveness to COVID-19   AHRQ intends to publish a new funding notice allowing requests for urgent revision supplements to existing AHRQ grants and cooperative agreements to address health system responsiveness to COVID-19.
NIH-AHRQ Competitive Revision Supplements to Existing AHRQ Health Service Research (HSR) Grants and Cooperative Agreements to Evaluate Health System and Healthcare Professional Responsiveness to COVID-19 (Supplement -  Clinical Trial Optional) 5/29/2020 PA-20-070. Applications are due by May 29, 2020 by 5:00 PM local time of applicant organization.   
NIH Common Fund Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) 4/15/2020 Notice Number: NOT-RM-20-015. The Office of Strategic Coordination (OSC), which manages the Common Fund, is issuing this Notice of Special Interest (NOSI) to stimulate innovative research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the disease it causes, Coronavirus Disease 2019 (COVID-19). OSC seeks new, innovative perspectives and approaches to the prevention of, preparation for, or response to coronavirus SARS-CoV-2, domestically or internationally. The funding for this supplement is provided from the Coronavirus Aid, Relief, and Economic Security (CARES) Act, 2020. First Available Due Date: April 15, 2020 Expiration Date: June 20, 2020
NIH-NCATS Notice of Change in Eligibility and Activity Codes for NOT-TR-20-011, Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need  
Notice Number:NOT-TR-20-018

The dual purpose of this Notice is to expand the eligibility and activity codes to include U24 parent awards. Changes are in italics.

NIH-NCATS Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions and Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs 5/4/2020 Notice Number: NOT-TR-20-028. The National Center for Advancing Translational Sciences (NCATS) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for projects that address the COVID-19 Public Health Emergency. The Clinical and Translational Science Award (CTSA) Program is uniquely qualified to contribute to these efforts. NCATS is soliciting applications for Administrative Supplements (through PA-18-591) and Emergency Competitive Revisions (through PA-20-135) from current Clinical and Translational Science Award (CTSA) UL1 and U24 award recipients
NIH-NCATS Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need 5/4/2020 Notice Number: NOT-TR-20-011 First Available Due Date: May 04, 2020 Expiration Date: July 10, 2021. National Center for Advancing Translational Sciences (NCATS) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on the 2019 novel Coronavirus (COVID-19). NCATS is particularly interested in projects focusing on the use of informatics solutions to diagnose cases and the use of CTSA-supported core resources (e.g., advanced scientific instruments, highly-specialized facilities, and regulatory expertise) to facilitate research on COVID-19 and advance the translation of research findings into diagnostics, therapeutics, and vaccines
NIH-NCCIH Notice of Special Interest (NOSI): Availability of Administrative Supplements and Urgent Competitive Revisions for Research on Stress Management in Relation to Coronavirus Disease 2019 (COVID-19)  

Notice Number: NOT-AT-20-011

NCCIH is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on the 2019 Novel Coronavirus (2019-nCoV, also known as COVID-19). Topics of specific interest for this NOSI include research on stress management strategies, including mind and body approaches, that individuals may engage in remotely to address stressors related to social distancing, as well as to address recovery and recurrence of symptoms during and after COVID-19 infections. pplications will be accepted on a rolling basis through October 6, 2020 by 5:00 p.m. local time of the applicant organization. This NOSI expires on October 7, 2020.

NIH-NCI Notice of Special Interest (NOSI): National Cancer Institute (NCI) Emergency Administrative Supplements for Research and Training Continuity of Postdoctoral Fellows during Coronavirus Disease 2019 (COVID-19) 7/6/2020
Notice Number: NOT-CA-20-082
Release Date: July 6, 2020
First Available Due Date: July 6, 2020
Expiration Date: August 15, 2020
NIH-NCI 7/22/2020
Notice Number: NOT-CA-20-076 Release Date: July 10, 2020 The purpose of this Notice is to add    that "no late applications will be accepted" for the July 22, 2020, Application Due Date in RFA-CA-20-039 "Emergency Awards: Research Projects in SARS-CoV-2 Serological Sciences (U01 Clinical Trial Optional)".
NIH-NCI Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence (U54 Clinical Trial Optional)   RFA-CA-20-038  Soliciting applications to establish Serological Sciences Centers of Excellence with a main goal of identifying and advancing research characterizing the immune responses elicited by SARS-CoV-2 viral infection. This FOA solicits multi-component U54 Center applications, whereas the companion FOA, RFA-CA-20-039, solicits applications for discrete U01 research projects. Successful applicants from both FOAs will become members of the Serological Sciences Network. 
NIH-NCI Notice of Information: Contributing to the Global COVID-19 Crisis Response by Allowing Some NCI-supported Projects to be Redirected to COVID-19-related Research During the Crisis   NCI anticipates that in infrequent cases, NCI-funded investigators will have novel insights and research proposals of immediate relevance to SARS-CoV-2 and COVID-19. In those cases, but only for the duration of the present crisis, NCI would consider requests from its funded grantees and cooperative agreement awardees to engage in limited COVID-19 related research using part of their existing NCI-funded resources...
NIH-NCI Notice of Special Interest (NOSI): National Cancer Institute Announcement regarding Availability of Competitive Revision SBIR/STTR Supplements on Coronavirus Disease 2019 (COVID-19)   Notice Number: NOT-CA-20-043 Applications will be accepted on a rolling basis from April 14, 2020, through June 25, 2020, by 5:00 PM local time of the applicant organization. This NOSI expires on June 26, 2020. An application submitted in response to this NOSI that is received on June 26, 2020, or later will be withdrawn.
NIH-NCI Notice of Special Interest (NOSI): National Cancer Institute Announcement Regarding Availability of Urgent Competitive Revision and Administrative Supplements on Coronavirus Disease 2019 (COVID-19)   Notice Number: NOT-CA-20-042 Applications will be accepted on a rolling basis from April 14, 2020, through June 25, 2020, by 5:00 PM local time of the applicant organization. This NOSI expires on June 26, 2020.
NIH-NCI-NIAID Concept Clearance: NCI-NIAID Serological Sciences Network for SARS-CoV-2    The National Cancer Institute (NCI) Board of Scientific Advisors held their Advisory Council meeting and announced a Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) concept based on a collaboration between NCI and the National Institute of Allergy and Infectious Disease (NIAID).  The purpose of this concept clearance is to mobilize collaborative efforts to rapidly expand national testing capacity.  This appears to be the first concept clearance for Coronavirus Disease 2019 (COVID-19) related research considered and approved by an NIH Institute Advisory Council. Next Steps: NCI plans to publish a Notice of Intent to Publish as well as a Request for Information (RFI) seeking input on the strategy for research in Coronavirus Serology Testing and Serological Sciences within the coming weeks.
NIH-NHGRI Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus   Notice Number: NOT-HG-20-030 Applications will be accepted on a rolling basis from April 1 through May 15, 2020
NIH-NHLBI Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions on Coronavirus Disease 2019 (COVID-19) for Currently Active NHLBI Phase I-III Clinical Trials 5/1/2020 NOT-HL-20-782. NHLBI is issuing this Notice of Special Interest (NOSI) due to the urgent need for early phase clinical trials to evaluate new or existing interventions that may prevent or treat Coronavirus Disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
NIH-NHLBI Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) 3/17/2020 Notice Number: NOT-HL-20-757
NIH-NHLBI Partnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed) 6/29/2020 RFA-AI-20-028
NIH-NIA Frequently Asked Questions for NOT-AG-20-022 Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)   Notice Number: NOT-AG-20-031
NIH-NIA Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)   Notice Number: NOT-AG-20-022 In order to rapidly improve our understanding and available control measures for 2019-nCoV, NIA is encouraging the submission of applications for either Administrative Supplements (PA-18-591) or Competitive Revisions (PA-18-935) to active grants to address the following research areas of interest. Applications will be accepted on a rolling basis from April 6, 2020 through May 1, 2021
NIH-NIAAA Notice of Special Interest: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA 5/15/2020 Notice Number: NOT-AA-20-011
NIH-NIAID Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Select Research Activities related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) 7/2/2020
Notice Number: NOT-AI-20-059
Release Date: July 6, 2020
First Available Due Date: July 02, 2020
Expiration Date: July 02, 2021
NIH-NIAID Notice of Special Interest (NOSI): Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) 6/16/2020 NOT-AI-20-051 
Release Date: May 19, 2020
First Available Due Date: June 16, 2020
Expiration Date: September 08, 2021
NIH-NIAID Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed)   PAR-20-177 The purpose of this Funding Opportunity Announcement (FOA) is to provide an expedited funding mechanism for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). NIAID is issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS, for 2019 Novel Coronavirus (COVID-19). Applications will be accepted on a rolling basis, beginning on 04/30/2020.
NIH-NIAID Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed)   PAR-20-178 The purpose of this Funding Opportunity Announcement (FOA) is to provide an expedited funding mechanism for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). NIAID is issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS, for 2019 Novel Coronavirus (COVID-19). Applications will be accepted on a rolling basis, beginning on 04/30/2020.
NIH-NIAID Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)   Notice Number: NOT-AI-20-034 Applications will be accepted on a rolling basis 03/25/2020 from 03/25/2021
NIH-NIAID Notice of Special Interest (NOSI): Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)   Notice Number: NOT-AI-20-030 This notice applies to due dates on or after April 5, 2020 and subsequent receipt dates through April 5, 2021.
NIH-NIAID 2020 NIAID Omnibus Broad Agency Announcement 4/9/2020 HHS-NIH-NIAID-BAA2020-1
NIH-NIAID Notice of Early Expiration of "Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV)," NOT-AI-20-030   Notice Number: NOT-AI-20-040 The purpose of this Notice is to inform the extramural community that NOT-AI-20-030, “Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV)” will be rescinded as of 04/08/2020 . NOT-AI-20-030 will be replaced by NOT-AI-20-034 for NIAID competitive revisions and NOT-GM-20-025 for NIGMS competitive revisions,
NIH-NIAID Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus 2/6/2020 Notice Number: NOT-AI-20-030 Rolling basis. Please see early expiration notice above.
NIH-NIAID Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trial Not Allowed) 9/9/2020 PAR-18-781
NIH-NIAID Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) 5/13/2020 PAR-20-139
NIH-NIAID Partnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed) 6/29/2020
Antiviral categories supported by this FOA include, but are not limited to, broad-spectrum antivirals, immunotherapeutics ... COVID-19
NIH-NIAD Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trial Not Allowed) 9/9/2020 mouse models has addressed the impact of host genetic variation on immunity to emerging viral pathogens, including Norovirus, severe acute respiratory coronavirus (SARS-CoV), Ebola, West Nile Virus, Dengue virus, Zika virus, Hepatitis C virus),
NIH-NIAMS Notice of NIAMS Participation in PA-20-135, "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)"  
Notice Number: NOT-AR-20-020 Release Date: July 6, 2020The purpose of this Notice is to inform potential applicants that the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) will participate, effective immediately, in PA-20-135, "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)".
NIH-NIBIB Rapid Acceleration of Diagnostics (RADx) Program   The Rapid Acceleration of Diagnostics (RADx) program will leverage the existing Point-of-Care Technology Research Network (POCTRN) supported by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) to support novel solutions to ramp up national capacity for SARS-CoV-2 testing. NIBIB is urgently soliciting proposals and will provide up to $500 million across multiple projects to produce SARS-CoV-2 diagnostic tests. The RADx program will support all phases of product development from conceptualization and design to prototyping, performance evaluation, clinical validation, and manufacturing. Proposals will be accepted on a rolling basis starting April 29 and will be reviewed within a week of submission.
NIH-NIDCD Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) 6/2/2020 NIDCD is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) in relation to NIDCD’s scientific mission areas of hearing, balance, taste, smell, voice, speech and language.
NIH-NIDCD Notice of Eligibility Change for NIDCD Urgent Competitive Revisions and Administrative Supplements for Research on COVID-19   Notice Number: NOT-DC-20-006 The purpose of this Notice is to revise the language regarding the activity codes of currently funded NIDCD grants that are eligible to apply to NOT-DC-20-004, Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19).
NIH-NIDCR NIDCR Announces Availability of Frequently Asked Questions (FAQs) for Coronavirus Disease 2019 (COVID-19)-Related Notices of Special Interest (NOSI) NOT-DE-20-022 and NOT-DE-20-023   NOT-DE-20-025 The purpose of this Notice is to inform potential applicants that NIDCR has posted a set of responses to Frequently Asked Questions (FAQs) regarding NOT-DE-20-022 “Notice of Special Interest (NOSI):  Availability of Urgent Competitive Revisions and Administrative Supplements for Coronavirus Disease 2019 (COVID-19) Research within the Mission of NIDCR” and NOT-DE-20-023 “Notice of Special Interest (NOSI):  Infrastructure Access for Research on Coronavirus Disease 2019 (COVID-19) Conducted in the National Dental Practice-Based Research Network”. The FAQs are available on the NIDCR website at the following link: https://www.nidcr.nih.gov/grants-funding/funding-opportunities/NOT-DE-20-022-NOT-DE-20-023-FAQS.
NIH-NIDA Notice of Special Interest (NOSI): Utilizing Telemedicine or Other Remote-Based Platforms to Develop and Support Treatments for Substance Use Disorders 10/5/2020 NOT-DA-20-058. Release Date: June 29, 2020. First Available Due Date: October 05, 2020. There is an urgent need for remotely delivered Substance Use Disorder (SUD) treatments to reduce patient burden and for methods to conduct clinical trials remotely. The purpose of this NOSI is to stimulate research to evaluate the safety and efficacy of telemedicine or remotely provided treatments for SUD, and to develop tools for remote collection of data in clinical trials of treatments for SUD.
NIH-NIDA Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus 3/19/2020 Notice Number: NOT-DA-20-047 supplement to existing awards. 
NIH-NIDDK Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional) 11/16/2020 RFA-DK-20-021 
Posted Date July 10, 2020
Letter of Intent Due Date(s) November 16, 2020
Application Due Date(s) December 16, 2020
NIH-NIDDK Notice of Additional Activity Code Accepted for "NOT-DK-20-018, Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIDDK"   NOT-DK-20-026. The purpose of this Notice is to add the U24 activity code to the activity codes eligible for submissions and adjust the language for parent awards to be eligible under NOT-DK-20-018: Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIDDK.
NIH-NIDDK Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) Related to HIV Comorbidities, Coinfections, and Complications within NIDDK's Mission 6/1/2020 Notice Number: NOT-DK-20-020  Release Date: April 09, 2020
First Available Due Date: June 01, 2020
Expiration Date: June 02, 2020
NIH-NIDDK Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIDDK 6/1/2020 First Available Due Date: June 01, 2020
Expiration Date: June 02, 2020
NIH-NIEHS Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) 5/1/2020 Notice Number: NOT-ES-20-020 Release Date: April 10, 2020
First Available Due Date: May 01, 2020
Expiration Date: May 04, 2021
NIH-NIGMS Notice of Special Interest (NOSI): Availability of Urgent Award for Competitive Revisions to IDeA-CTR Awards to Address the Need for Documenting 2019 Novel Coronavirus Disease (COVID-19)-Related Patient Outcomes 6/18/2020 NOT-GM-20-033 NIGMS is issuing this Notice of Special Interest (NOSI) to highlight the urgent need of documenting COVID-19-related patient outcomes among medically underserved populations.
NIH-NIGMS Notice of Special Interest (NOSI): Urgent Competitive Revisions to Accelerate Research on the Development of Predictive Models of the Spread of SARS-CoV-2 and Outcomes of Potential Public Health Interventions on COVID-19   Notice Number: NOT-GM-20-027 

Applications in response to this NOSI must be submitted to PA-18-935 "Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)", which is intended to provide funds for NIH grantees applying to expand the scope of their active U24 award. The activity code will be the same as that of the parent award.

NIH-NIMH Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus   Notice Number: NOT-MH-20-047 Applications will be accepted on a rolling basis through April 15, 2021 by 5:00 PM local time of the applicant organization. This NOSI expires on April, 16, 2021.
NIH-NIMHD Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities 5/1/2020

Notice Number: NOT-MD-20-019 First Available Due Date: May 01, 2020 Expiration Date: May 01, 2021. The National Institute on Minority Health and Health Disparities (NIMHD) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on the impact of the novel Coronavirus (SARS-CoV-2) pandemic causing COVID-19 disease outbreaks and the resulting disruptions on individual and social wellbeing, health services use, and health outcomes for NIH-designated health disparity populations.

NIH-NINDS Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System 5/1/2020

Notice Number: NOT-NS-20-05 First Available Due Date: May 01, 2020 Expiration Date: April 15, 2021. NINDS is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on Coronavirus Disease 2019 (COVID-19) and on biological effects on the nervous system of its causative agent, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Research of interest must fall within NINDS’s scientific mission, which is to support basic, translational, and clinical neuroscience research to expand fundamental knowledge about the brain and nervous system and to use that knowledge to reduce the burden of neurological disease.

NIH-NINDS Notice of Special Interest regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for the Establishment and Maintenance of a Research Database for Neurological Manifestations of the SARS-CoV-2   Notice Number: NOT-NS-20-046. First Available Due Date: April 06, 2020 Expiration Date: May 09, 2020. NINDS is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on the novel coronavirus SARS-CoV-2 (previously termed 2019-nCoV) and its associated illness, COVID-19. NINDS is especially interested in developing systems to collect data on the neurologic effects of COVID-19 infection in patients requiring intensive care and less severely affected individuals seen by health care practitioners
NIH-NLM Notice of Special Interest (NOSI): Data Driven Research on Coronavirus Disease 2019 (COVID-19) (R21) 6/16/2020
Notice Number: NOT-LM-20-011. NLM is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for innovative high-risk/high impact research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) in relation to NLM’s strategic goal of fostering data driven research.
NIH-NLM Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) 6/1/2020 Notice Number: NOT-LM-20-010. NLM is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) in relation to NLM’s strategic goal of fostering data driven research.
NIH-OBSSR Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences 4/13/2020

Notice Number: NOT-OD-20-097 First Available Due Date: April 13, 2020 Expiration Date: April 01, 2021. This Notice of Special Interest (NOSI) highlights the urgent need for social, behavioral, economic, health communication, and epidemiologic research relevant to the 2019 Novel Coronavirus (SARS-CoV-2) and COVID-19.

NIH-OMH National Infrastructure for Mitigating the Impact of COVID-19 within Racial and Ethnic Minority Communities 5/11/2020 MP-CPI-20-006 The Office of Minority Health (OMH) is offering a funding opportunity to support the development and coordination of a national-state/territorial/tribal-local network of public and community-based organizations that will disseminate COVID-19-related information; disseminate effective response, recovery and resilience strategies; and ensure service linkages for racial and ethnic minority, rural and disadvantaged communities hardest hit by the COVID-19 pandemic.
NSF Dear Colleague Letter: Supporting Research on Pandemics within the Civic Innovation Challenge and Broadened NSF Support for the Challenge 8/3/2020

With this Dear Colleague Letter (DCL), the National Science Foundation (NSF) wishes to notify the community that research projects focused on pandemics are considered appropriate for the Civic Innovation Challenge (CIVIC; NSF 20-562), a research and action competition in the smart and connected communities (S&CC) domain.

Additionally, NSF wishes to notify the community of broadened NSF support for CIVIC. Together with the NSF directorates and federal partners listed in the solicitation – NSF's directorates for Computer and Information Science and Engineering (CISE) and Social, Behavioral and Economic Sciences (SBE), the U.S. Department of Energy's Vehicles Technologies Program, and the U.S. Department of Homeland Security's Science and Technology Directorate – NSF's division of Civil, Mechanical and Manufacturing Innovation (CMMI) within its directorate for Engineering (ENG) is now also supporting CIVIC.

NSF Research Experiences for Undergraduates Supplemental Funding in Computer and Information Science and Engineering   CISE will prioritize REU supplemental funding requests most responsive to the mitigation of adverse undergraduate employment and education circumstances caused by the COVID-19 pandemic, and such requests are anticipated to provide for undergraduate research experiences this Summer and/or Fall. Supplemental funding requests should explain how students will be mentored if the awardee organization is closed, for example, through virtual mentorship experiences.
NSF Dear Colleague Letter: Request for SBIR/STTR Phase I Proposals Addressing COVID-19   All active NSF SBIR/STTR awardees, and other interested US-based small businesses are eligible to submit a Phase I proposal. Please reference the NSF SBIR and STTR Phase I solicitations for more details regarding eligibility.
NSF Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19)   Before submitting a RAPID proposal or supplemental funding request in response to this DCL, investigators must first contact one of the cognizant OAC program officers listed
NSF Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19)   check with PO
PCORI Notice of Upcoming PCORI Funding Announcement: COVID-19 Targeted PFA 5/26/2020

(PCORI) will release its COVID-19 Targeted PCORI Funding Announcement (PFA) on May 5, 2020

This funding announcement’s three targeted priority areas are:

  • Adaptations to healthcare delivery
  • Impact of COVID-19 on vulnerable populations
  • Impact of COVID-19 on healthcare workforce well-being, management, and training
PCORI “Supporting Engagement in and Dissemination of PCOR/CER in the Context of COVID-19.” 5/22/2020 PCORI intends to award $21 million to research support projects that encourage the integration of community and healthcare stakeholders into patient-centered outcomes research/comparative clinical effectiveness research (PCOR/CER) on COVID-19. This Engagement Award Funding Opportunity opened on Monday, April 20, 2020.
Applications are due Friday, May 22, 2020 by 5:00 p.m. ET.
Pfizer Pfizer’s Global Medical Grants program 6/17/2020 The intent of this Request for Proposal (RFP) is to support research to increase knowledge of COVID-19 epidemiology, infection, pathophysiology, and potential prevention measures. Grant Application RFP closing date: June 17, 2020 however Pfizer will review and make funding decisions on all applications within 10-14 days of submission.
 
Robert Wood Johnson Foundation Systems for Action: Supplemental Research on COVID-19 Response and Recovery 7/20/2020 This call for proposals (CFP) will provide supplemental research funding to teams that are already engaged in the study of a promising system alignment mechanism, with the objective of learning how this mechanism performs in addressing health and social needs during the COVID-19 pandemic.
Russell Sage Foundation New Funding Guidelines for May 21 Deadline 5/21/2020  
Smart Cville

Microgrants for Community Based Responses to COVID-19

  Each microgrant is worth up to $200 and grant applications will be open until the money is exhausted.
USAID  USAID Releases NOFO for Strategies to Prevent (STOP) Spillover of Emerging Zoonotic Viruses 6/1/2020

 

The NOFO aims to reduce the vulnerability of countries in Asia and Africa to “spillover of emerging zoonotic viruses from animal hosts (such as livestock or wildlife) to humans and amplification and spread of these viruses once they have spilled over to humans.”  Responses are due by June 1, 2020 at 1:00pm ET to stopspillover@usaid.gov.  Any questions on the NOFO must be submitted to USAID through stopspillover@usaid.gov by May 11, 2020 at 1:00pm ET.

USAID COVID-19 Funding Requests and Unsolicited Proposals   We encourage potential partners to continue monitoring https://www.grants.gov/ and https://beta.sam.gov/ (new fedbizops) for new grant and contract opportunities related to COVID-19. Partners may submit unsolicited proposals to COVID19_Concepts@usaid.gov.
UVA Provost and VPR Manning Fund for COVID-19 Research 5/15/2020 The Manning Fund for COVID-19 Research is a newly established innovation fund co-managed by the Provost and the VPR offices for supporting research focused on testing, therapies, vaccines, and ways to reopen society. The intent of this fund is to support practically oriented research on COVID-19 related topics that can be acted upon and/or preferably has a commercialization potential. 
VBHRC Virginia Catalyst Announces Round 11 of Grant Funding Emphasis will be placed on Innovative Projects Focused on Solutions for COVID-19 and other Infectious Disease 6/30/2020 LOIs must be received by June 30, 2020 at 5:00 PM EDT. Projects that meet criteria will be invited to submit a full application by August 18, 2020
XSEDE COVID-19 HPC Consortium   Continuous submission. To request access to resources of the COVID-19 HPC Consortium, you must prepare a description, no longer than two pages, of your proposed work.